Literature DB >> 22926191

Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.

Gladys Chompre1, Emmanuel Cruz2, Lucianette Maldonado1, Vanessa Rivera-Amill3, James T Porter2, Richard J Noel4.   

Abstract

Despite the widespread use of antiretroviral therapy that effectively limits viral replication, memory impairment remains a dilemma for HIV infected people. In the CNS, HIV infection of astrocytes leads to the production of the HIV-1 Nef protein without viral replication. Post mortem studies have found Nef expression in hippocampal astrocytes of people with HIV associated dementia suggesting that astrocytic Nef may contribute to HIV associated cognitive impairment even when viral replication is suppressed. To test whether astrocytic expression of Nef is sufficient to induce cognitive deficits, we examined the effect of implanting primary rat astrocytes expressing Nef into the hippocampus on spatial and recognition memory. Rats implanted unilaterally with astrocytes expressing Nef showed impaired novel location and novel object recognition in comparison with controls implanted with astrocytes expressing green fluorescent protein (GFP). This impairment was correlated with an increase in chemokine ligand 2 (CCL2) expression and the infiltration of peripheral macrophages into the hippocampus at the site of injection. Furthermore, the Nef exposed rats exhibited a bilateral loss of CA3 neurons. These results suggest that Nef protein expressed by the implanted astrocytes activates the immune system leading to neuronal damage and spatial and recognition memory deficits. Therefore, the continued expression of Nef by astrocytes in the absence of viral replication has the potential to contribute to HIV associated cognitive impairment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; CCL2; CD163; Cognition; HAND

Mesh:

Substances:

Year:  2012        PMID: 22926191      PMCID: PMC3530662          DOI: 10.1016/j.nbd.2012.08.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  60 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia.

Authors:  K A Thompson; J C McArthur; S L Wesselingh
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

3.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Authors:  Mikulas Popovic; Klara Tenner-Racz; Colleen Pelser; Hans-Jurgen Stellbrink; Jan van Lunzen; George Lewis; Vaniambadi S Kalyanaraman; Robert C Gallo; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system.

Authors:  U Koedel; B Kohleisen; B Sporer; F Lahrtz; V Ovod; A Fontana; V Erfle; H W Pfister
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

5.  Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?

Authors:  E Koutsilieri; S Czub; C Scheller; S Sopper; T Tatschner; C Stahl-Hennig; V ter Meulen; P Riederer
Journal:  Neuroreport       Date:  2000-08-03       Impact factor: 1.837

6.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 7.  Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies.

Authors:  Tracy Fischer-Smith; Christie Bell; Sidney Croul; Mark Lewis; Jay Rappaport
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

8.  Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia.

Authors:  A Ranki; M Nyberg; V Ovod; M Haltia; I Elovaara; R Raininko; H Haapasalo; K Krohn
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

Review 9.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.

Authors:  W Kelder; J C McArthur; T Nance-Sproson; D McClernon; D E Griffin
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  38 in total

1.  Dysregulation of autophagy by HIV-1 Nef in human astrocytes.

Authors:  A Sami Saribas; Kamel Khalili; Ilker Kudret Sariyer
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

Review 2.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Authors:  Kenta Matsuda; Chia-Yen Chen; Sonya Whitted; Elena Chertova; David J Roser; Fan Wu; Ronald J Plishka; Ilnour Ourmanov; Alicia Buckler-White; Jeffrey D Lifson; Klaus Strebel; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

Review 4.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

Review 5.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

6.  Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice.

Authors:  James P Kesby; Robert K Heaton; Jared W Young; Anya Umlauf; Steven P Woods; Scott L Letendre; Athina Markou; Igor Grant; Svetlana Semenova
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

7.  Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells.

Authors:  Fengchun Ye; David Alvarez-Carbonell; Kien Nguyen; Konstantin Leskov; Yoelvis Garcia-Mesa; Sheetal Sreeram; Saba Valadkhan; Jonathan Karn
Journal:  PLoS Pathog       Date:  2022-07-07       Impact factor: 7.464

8.  Brain-specific HIV Nef identified in multiple patients with neurological disease.

Authors:  Susanna L Lamers; Gary B Fogel; Enoch S Liu; Andrew E Barbier; Christopher W Rodriguez; Elyse J Singer; David J Nolan; Rebecca Rose; Michael S McGrath
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

9.  Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes.

Authors:  Pia Pužar Dominkuš; Jana Ferdin; Ana Plemenitaš; Boris Matija Peterlin; Metka Lenassi
Journal:  J Neurovirol       Date:  2017-07-31       Impact factor: 2.643

Review 10.  HIV-1 and Compromised Adult Neurogenesis: Emerging Evidence for a New Paradigm of HAND Persistence

Authors:  Raj Putatunda; Wen-Zhe Ho; Wenhui Hu
Journal:  AIDS Rev       Date:  2019       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.